uce
ProgressImage ProgressImage
Alembic Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 533573 border-img ISIN Demat INE901L01018 border-img Book Value 264.28 border-img NSE Symbol APLLTD border-img Div & Yield % 1.08 border-img Market Cap ( Cr.) 19943.29 border-img P/E 40.8 border-img EPS 24.87 border-img Face Value 2
Quarters
ParticularsMar 2025
()
Dec 2024
()
Sep 2024
()
Gross Sales1570.641406.091580.35
Other Operating Income0.000.000.00
Other Income 13.2115.4628.93
Total Income1583.851421.551609.28
Total Expenditure 1399.981226.261320.86
PBIDT183.87195.29288.42
Interest 23.7121.7918.28
PBDT160.16173.50270.14
Depreciation68.6069.6970.12
Tax16.2218.0034.24
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax75.3485.81165.78
Extra-ordinary Items 0.000.0010.67
Adjusted Profit After Extra-ordinary item75.3485.81155.11
    
EPS (Unit Curr.)3.834.378.43
EPS (Adj) (Unit Curr.)3.834.378.43
Calculated EPS (Unit Curr.)3.834.378.43
Calculated EPS (Adj) (Unit Curr.)3.834.378.43
Calculated EPS (Ann.) (Unit Curr.)15.3317.4633.74
Calculated EPS (Adj) (Ann.) (Unit Curr.)15.3317.4633.74
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity39.3139.3139.31
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)11.7113.8918.25
PBDTM(%)10.2012.3417.09
PATM(%)4.806.1010.49
x
x
×
Let's Chat
close
refresh